Atria Investments LLC Novartis Ag Transaction History

Atria Investments LLC

  • $7.56 Billion
  • Q3 2024

A detailed history of Atria Investments LLC transactions in Novartis Ag stock. As of the latest transaction made, Atria Investments LLC holds 46,040 shares of NVS stock, worth $4.53 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
46,040
Previous 45,849 0.42%
Holding current value
$4.53 Million
Previous $4.88 Million 8.48%
% of portfolio
0.07%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$106.13 - $120.89 $20,270 - $23,089
191 Added 0.42%
46,040 $5.3 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $243,644 - $282,597
-2,632 Reduced 5.43%
45,849 $4.88 Million
Q1 2024

May 21, 2024
BUY
$95.27 - $108.47 $365,265 - $415,873
3,834 Added 8.59%
48,481 $4.69 Million
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $81,013 - $89,152
-878 Reduced 1.93%
44,647 $4.51 Million
Q3 2023

Nov 07, 2023
BUY
$94.73 - $105.13 $195,143 - $216,567
2,060 Added 4.74%
45,525 $4.64 Million
Q2 2023

Aug 04, 2023
SELL
$92.52 - $104.91 $254,985 - $289,131
-2,756 Reduced 5.96%
43,465 $4.39 Million
Q1 2023

May 10, 2023
SELL
$80.03 - $92.81 $1.4 Million - $1.62 Million
-17,452 Reduced 27.41%
46,221 $4.25 Million
Q4 2022

Jan 31, 2023
SELL
$75.55 - $92.52 $229,596 - $281,168
-3,039 Reduced 4.56%
63,673 $5.78 Million
Q3 2022

Nov 01, 2022
SELL
$74.61 - $87.26 $273,072 - $319,371
-3,660 Reduced 5.2%
66,712 $5.07 Million
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $377,880 - $439,968
-4,693 Reduced 6.25%
70,372 $5.95 Million
Q1 2022

May 02, 2022
SELL
$80.11 - $90.62 $121,767 - $137,742
-1,520 Reduced 1.98%
75,065 $6.59 Million
Q4 2021

Feb 04, 2022
SELL
$79.7 - $88.13 $1.43 Million - $1.58 Million
-17,971 Reduced 19.01%
76,585 $6.7 Million
Q3 2021

Nov 16, 2021
BUY
$81.78 - $95.14 $339,959 - $395,496
4,157 Added 4.6%
94,556 $7.73 Million
Q2 2021

Aug 10, 2021
BUY
$85.24 - $94.15 $577,245 - $637,583
6,772 Added 8.1%
90,399 $8.25 Million
Q1 2021

May 11, 2021
SELL
$83.5 - $98.47 $317,216 - $374,087
-3,799 Reduced 4.35%
83,627 $7.15 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $1.33 Million - $1.61 Million
17,070 Added 24.26%
87,426 $8.26 Million
Q3 2020

Nov 05, 2020
BUY
$82.14 - $91.0 $220,299 - $244,062
2,682 Added 3.96%
70,356 $6.12 Million
Q2 2020

Sep 22, 2020
BUY
$80.93 - $91.1 $683,049 - $768,884
8,440 Added 14.25%
67,674 $5.91 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $1.25 Million - $1.75 Million
17,659 Added 42.48%
59,234 $4.88 Million
Q4 2019

Feb 11, 2020
BUY
$84.35 - $95.37 $2.14 Million - $2.43 Million
25,429 Added 157.49%
41,575 $3.94 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $48,757 - $53,728
-570 Reduced 3.41%
16,146 $1.4 Million
Q2 2019

Aug 26, 2019
BUY
$75.4 - $92.8 $846,365 - $1.04 Million
11,225 Added 204.43%
16,716 $1.51 Million
Q2 2019

Aug 09, 2019
SELL
$75.4 - $92.8 $582,540 - $716,972
-7,726 Reduced 58.46%
5,491 $401,000
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $889,001 - $1.02 Million
-11,803 Reduced 47.17%
13,217 $1.27 Million
Q4 2018

Feb 12, 2019
SELL
$73.66 - $82.02 $83,235 - $92,682
-1,130 Reduced 4.32%
25,020 $2.15 Million
Q3 2018

Oct 09, 2018
BUY
$66.94 - $77.43 $180,001 - $208,209
2,689 Added 11.46%
26,150 $2.25 Million
Q2 2018

Jul 13, 2018
SELL
$64.91 - $73.36 $88,731 - $100,283
-1,367 Reduced 5.51%
23,461 $1.77 Million
Q1 2018

Apr 30, 2018
BUY
$70.39 - $84.15 $29,845 - $35,679
424 Added 1.74%
24,828 $2.01 Million
Q4 2017

Jan 16, 2018
BUY
$72.33 - $77.64 $169,903 - $182,376
2,349 Added 10.65%
24,404 $2.05 Million
Q3 2017

Oct 12, 2017
BUY
$74.14 - $77.27 $1.64 Million - $1.7 Million
22,055
22,055 $1.89 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email